Literature DB >> 31245065

The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.

Mathew Suji Eapen1, Archana Vijay Gaikwad1, Isobel E Thompson1, Wenying Lu1, Stephen Myers1, Pawan Sharma2,3, Sukhwinder Singh Sohal1.   

Abstract

Entities:  

Year:  2019        PMID： 31245065      PMCID： PMC6560594          DOI： 10.21037/jtd.2019.04.44

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  28 in total

Review 1.  Immunosuppression for interstitial lung disease in systemic sclerosis.

Authors:  Susanna Cappelli; Serena Guiducci; Silvia Bellando Randone; Marco Matucci Cerinic
Journal:  Eur Respir Rev       Date:  2013-09-01

2.  An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.

Authors:  Keith C Meyer; Ganesh Raghu; Robert P Baughman; Kevin K Brown; Ulrich Costabel; Roland M du Bois; Marjolein Drent; Patricia L Haslam; Dong Soon Kim; Sonoko Nagai; Paola Rottoli; Cesare Saltini; Moisés Selman; Charlie Strange; Brent Wood
Journal:  Am J Respir Crit Care Med       Date:  2012-05-01       Impact factor: 21.405

3.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

Review 4.  Mechanisms of action of cyclosporine.

Authors:  S Matsuda; S Koyasu
Journal:  Immunopharmacology       Date:  2000-05

Review 5.  Cyclosporine in transplantation - a history of converging timelines.

Authors:  D Colombo; E Ammirati
Journal:  J Biol Regul Homeost Agents       Date:  2011 Oct-Dec       Impact factor: 1.711

Review 6.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

Review 7.  The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses.

Authors:  M Rincón; R A Flavell; R A Davis
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

Review 8.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis.

Authors:  Ganesh Raghu; Kevin K Brown
Journal:  Clin Chest Med       Date:  2004-09       Impact factor: 2.878

Review 10.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.

Authors:  Eunice J Kim; Harold R Collard; Talmadge E King
Journal:  Chest       Date:  2009-11       Impact factor: 9.410
View more
  2 in total

1.  Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections.

Authors:  Wenying Lu; Mathew Suji Eapen; Gurpreet Kaur Singhera; James Markos; Greg Haug; Collin Chia; Josie Larby; Samuel James Brake; Glen P Westall; Jade Jaffar; Rama Satyanarayana Raju Kalidhindi; Nimesha De Fonseka; Venkatachalem Sathish; Tillie L Hackett; Sukhwinder Singh Sohal
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

2.  Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition.

Authors:  Archana Vijay Gaikwad; Wenying Lu; Surajit Dey; Prem Bhattarai; Collin Chia; Josie Larby; Greg Haug; Stephen Myers; Jade Jaffar; Glen Westall; Gurpreet Kaur Singhera; Tillie-Louise Hackett; James Markos; Mathew Suji Eapen; Sukhwinder Singh Sohal
Journal:  ERJ Open Res       Date:  2022-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.